Arizona Arthritis and Rheumatology Research Revenue and Competitors

Claim your profile

Phoenix, AZ USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Arizona Arthritis and Rheumatology Research's estimated annual revenue is currently $17.5M per year.(i)
  • Arizona Arthritis and Rheumatology Research's estimated revenue per employee is $243,000

Employee Data

  • Arizona Arthritis and Rheumatology Research has 72 Employees.(i)
  • Arizona Arthritis and Rheumatology Research grew their employee count by 9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.7M31N/AN/AN/A
#2
$4.3M23N/AN/AN/A
#3
$127.9M379-1%N/AN/A
#4
$2.9M18N/AN/AN/A
#5
$1.1M8-47%N/AN/A
#6
$101.6M301-4%N/AN/A
#7
N/A6211%N/AN/A
#8
$231.5M686-5%N/AN/A
#9
$0.4M3N/AN/AN/A
#10
$1.4M5N/AN/AN/A

Arizona Arthritis & Rheumatology Research (AARR) remains at the forefront of rheumatologic care by participating in clinical trials of new rheumatologic drugs and the enrollment and supervision of patients who qualify and who may be in need of other potentially effective therapies. In a clinical drug trial, medications are supplied at no cost to participating patients. Clinical trials may offer benefit to patients who have not responded to conventionally available treatments. As the research wing of Arizona Arthritis & Rheumatology Associates (AARA), we keep involved in the valuable process of new drug development. As long as people continue to suffer from the damage of immunologic illness and musculoskeletal disorders, medical scientists and pharmaceutical and device companies will forge ahead for the next advancement in treatment. Only real people with these disorders can move this science ahead for themselves and others who may suffer these disorders in the future. We encourage our patients whenever appropriate to consider contributing to medical science through enrollment in FDA supervised clinical trials.

keywords:N/A

N/A

Total Funding

72

Number of Employees

$17.5M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Arizona Arthritis and Rheumatology Research News

2022-04-20 - Gender differences in Egyptian fibromyalgia patients | OARRR

Methods: This is a prospective cross-sectional study that was carried out on 352 patients with FM in the Rheumatology Department,...

2022-04-13 - Bristol Myers Squibb's aging Orencia finds new life with ...

Bristol Myers Squibb's aging Orencia finds new life with rheumatologists as ... in AZ's phase 3 Provent trial entered the study with underlying conditions...

2022-02-22 - New UArizona Health Sciences Study to Focus on Link Between ...

Researchers at the University of Arizona Health Sciences are hoping to ... Arthritis Center and chief of the Division of Rheumatology in the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.7M72N/AN/A
#2
N/A7220%N/A
#3
$17.5M729%N/A
#4
$13.3M7222%N/A
#5
$15.9M72-15%N/A